Sep. 23 at 6:31 PM
                            
FDA approval: 3AmnealPharma (Nasdaq: 
$AMRX) wins ANDA for bimatoprost ophthalmic solution 0.01%, the generic equivalent of LUMIGAN®. Expands its Affordable Medicines portfolio, delivering lower-cost treatment for glaucoma & ocular hypertension patients. 
https://prismmarketview.com/fda-approves-amneals-generic-version-of-bimatoprost-ophthalmic-solution/